Company Overview of Domain Associates, L.L.C.
Domain Associates, L.L.C. is a private equity and venture capital firm specializing in investments in incubation, seed/start up, early venture, growth capital, PIPEs, and emerging growth companies. Within life sciences, it typically invests in healthcare companies with a focus on bio/pharmaceuticals, specialty pharmaceuticals, drug and device sectors, medical devices, biomaterials, bioinstrumentation, diagnostics, tools and instrumentation, and healthcare IT (HCIT). The firm prefers to be a part of the first institutional financing round of a company and may also invest at other stages. It prefers to takes a board seat in its portfolio companies. The firm may also invest in public companies....
One Palmer Square
Princeton, NJ 08542
Founded in 1985
Key Executives for Domain Associates, L.L.C.
Compensation as of Fiscal Year 2014.
Domain Associates, L.L.C. Key Developments
Domain Associates, L.L.C. Presents at Boston CEO Conference, Jun-05-2014 03:30 PM
Jun 2 14
Domain Associates, L.L.C. Presents at Boston CEO Conference, Jun-05-2014 03:30 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, Massachusetts, United States. Speakers: Brian K. Halak, Partner.
Domain Associates, L.L.C. Presents at Women's Alternative Investment Summit, Nov-08-2013 12:00 PM
Oct 2 13
Domain Associates, L.L.C. Presents at Women's Alternative Investment Summit, Nov-08-2013 12:00 PM. Venue: The Pierre - New York, 2 East 61st Street (at 5th Avenue), Midtown Manhattan, NY 10065, New York, United States. Speakers: Nicole Vitullo, Partner.
Domain Associates LLC and RUSNANO Announce Joint Venture to Build New Pharmaceutical Plant
Jul 25 13
The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region. The new plant will be built under a joint venture between Domain Associates LLC and RUSNANO. Around $85 million will be invested in NovaMedica's new plant. The size of the land plot, where NovaMedica's production facilities will be constructed, occupies a total surface area of 50,000 square meters. On-site construction is scheduled for the second half of 2013. The factory will focus on manufacturing innovative pharmaceutical products and medical devices, which will be licensed to NovaMedica under RUSNANO/Domain Associates Agreement and subject to joint financing of late-stage life sciences developments.
Similar Private Companies By Industry
Recent Private Companies Transactions